Total Funding
26
39
Total FundingGrant raised
Growth Score
-38 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
92125
BlueWillow is a biopharmaceutical company that focuses on developing and commercializing topical antiseptic and anti-infective products.
George Arida: Chief Financial and Operating OfficerPast Role: Clarevia Ventures, Managing Director
Robert C. Moellering: Member Of The Board Of DirectorsPast Role: Beth Israel Deaconess Medical Center, President & CEO, Harvard Medical Faculty Physicians
About the Company
BlueWillow Biologics operates as a clinical-stage, privately-held biopharmaceutical company. It focuses on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. Its platform employs novel oil-in-water nano-droplets for products administered to the skin and
nose.
The company was founded as a spin-off from the University of Michigan and is headquartered in Ann Arbor, Michigan.
